The AIM Biopsy Device is revolutionizing bone biopsy procedures with automation and precision.
Founders
Dr. Krupa Shah, Mr. Dr. Abhijeet Salunke, Dr. Raghavendra
Surgical Medical Device
The Problem:
Bone biopsies were traditionally performed manually using Jamshidi needles, requiring surgeons to rely on physical force and hand precision. This often resulted in inaccurate sampling, repeat procedures, and higher patient risk.
The Solution:
To bridge this critical gap, Dr. Krupa Shah and her co-founders developed the AIM Biopsy Device, a fully automated, powered solution that ensures accuracy without strain. With future plans for a telerobotic version, the innovation aims to make expert biopsy sampling accessible even in remote regions.
Who Benefits?
Ortho & Onco Ortho Surgeons
Trauma Care Practitioners
Pathology Labs
Patients needing orthopedic or bone marrow diagnostics
Key Achievements
Patent granted for innovation
Zydus Innovation Award 2025
NIDHI Prayas Grant
Seed Grant under iHub’s Srujan program
Supported by herSTART Accelerator
Prototype developed and validated
Societal Impact
The device transforms bone sampling by reducing human error and preventing over-penetration, thereby increasing patient safety. Future robotic features will expand access to advanced diagnostics across underserved regions.
Vision for the Future
Year 1: Medical certifications
Year 2: Commercialization of Version-1 across cancer centers.
Year 3: Version-2 with robotic & telerobotic capabilities.
